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The homologous bacterially expressed cholesterol-
dependent cytolysins (CDCs) form pores via oligo-
merization; this must occur preferentially once the
target membrane has been engaged. Conformational
changes in CDCs then drive partition from an aque-
ous environment to a lipidic one. This review ad-
dresses how premature oligomerization is prevented,
how conformational changes are triggered, and how
cooperativity between subunits brings about new
functionality absent from isolated protomers. Varia-
tions are found in the answers provided by the CDCs
to these issues. Some toxins use pH as a trigger of
activity, but recent results have shown that dimeriza-
tion in solution is an alternative way of preventing
premature oligomerization, in particular for the CDC
from Clostridium perfringens, perfringolysin. More
controversially, there is still no resolution to the de-
bate as to whether incomplete (arciform) oligomers
form pores: recent results again suggest that they do.
Introduction to Cholesterol-Dependent Cytolysins
The cholesterol-dependent cytolysins (CDCs) consti-
tute a large family of toxins expressed by Gram-posi-
tive bacteria that play roles in the pathogenic mecha-
nisms of their producing organisms (Morgan et al.,
1996; Tweten et al., 2001; Gilbert, 2002). Key members
of the family include pneumolysin from Streptococcus
pneumoniae, streptolysin from S. pyogenes, perfringo-
lysin from Clostridium perfringens, and listeriolysin
from Listeria monocytogenes. The structure of perfrin-
golysin is known from X-ray crystallography (Rossjohn
et al., 1997; Figure 1A), and on the basis of sequence
homology and identity, it can be confidently asserted
that the overall architecture of the other family mem-
bers will be similar (Rossjohn et al., 1998). These toxins
are capable of recognizing cholesterol in lipid mem-
branes with a fair degree of specificity (Howard et al.,
1953; Bernheimer, 1972; Rottem et al., 1976; Alouf and
Geoffroy, 1991), which affords them a receptor. By this
receptor they can associate with the membrane sur-
face, oligomerize into large ring-shaped structures, in-
sert into the hydrophobic membrane core, and so form*Correspondence: gilbert@strubi.ox.ac.ukpores. As a result, their pore-forming activity can be
reconstituted in cholesterol-containing liposomes and
planar lipid bilayers (Menestrina et al., 1990, Shepard
et al., 1998, 2000; Heuck et al., 2000; Hotze et al., 2002;
Czajkowsky et al., 2004). It has also been shown that
the CDC listeriolysin will bind to membranes if it has
previously bound a molecule of cholesterol, but will not
then oligomerize (Jacobs et al., 1998). Furthermore, de-
pletion of cholesterol from cell membranes has sug-
gested that pore formation is more critically dependent
on interaction with cholesterol than actual membrane
binding (Giddings et al., 2003). Two comments can be
made concerning these insights: first, that it is never-
theless clearly the case that the presence of cholesterol
in a target membrane is necessary and sufficient for
attack by a CDC; second, that it may be that in vivo
CDCs make use of a protein receptor in addition to cho-
lesterol. Recently, a protein receptor for the CDC inter-
medilysin was identified, but it must be noted that inter-
medilysin is different from all other known CDCs in that
it is not actually dependent on cholesterol for mem-
brane binding, but is for pore formation (Giddings et al.,
2004). Instead, intermedilysin has a protein receptor,
CD59 (Giddings et al., 2004). Mutations in the choles-
terol binding region of the toxin important for mem-
brane interaction in the other CDCs give rise to inter-
medilysin’s different behavior (Giddings et al., 2004;
Nagamune et al., 2004; Polekhina et al., 2005). Whether
other CDCs make use of a protein receptor remains to
be seen.
Following binding to the membrane, a well-defined
series of events takes place, resulting in pore formation
(Figure 2). Initially, a prepore state assembles, which
then converts to a pore: this mechanism for the assem-
bly of pore-forming complexes and the transition of
proteins from solution to membrane states was first set
out by Bayley and colleagues, on the basis of the α-hemo-
lysin of S. aureus (Walker et al., 1995). Monomeric CDCs
interact, via their fourth domains to start with (Gilbert
et al., 1998, 1999b; Weis and Palmer, 2001), to form the
oligomeric prepore (Shepard et al., 2000; Hotze et al.,
2001). These prepores consist of toxin molecules in
largely the same conformation as before membrane
binding (Czajkowsky et al., 2004; Tilley et al., 2005) (Fig-
ures 2A and 2D). Prepores can be visualized bound to
liposomes by using cryo-electron microscopy (cryo-
EM): in actual fact, our initial report of reconstructions
of membrane bound CDC (pneumolysin) oligomers er-
roneously suggested that they were pores, not pre-
pores (Gilbert et al., 1999a), as previously discussed
(Gilbert, 2002), but subsequent work has allowed the
determination of the structure of both prepore and pore
states (Tilley et al., 2005). Within prepore oligomers, do-
mains 4 do not form close intersubunit contacts; rather,
the major interactions occur through domains 1 and 3
(Weis and Palmer, 2001; Ramachandran et al., 2002; Til-
ley et al., 2005). There is then a dramatic refolding of
the prepore to generate a transmembrane channel and
thus the pore by the insertion of domain 3, substantially
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Figure 1. Overview of CDC Structure and Mechanism s
(A) The crystal structure of perfringolysin, with its four domains la- f
beled (Rossjohn et al., 1997). The six helices that refold into β 1
strands in the pore-forming state of the toxin are colored cerise in
2domain 3, and the tryptophan-rich loop through which CDCs con-
ctact cholesterol is colored likewise in domain 4. This image was
adrawn by using Bobscript and was rendered in Raster3D (Esnouf,
1999; Merritt and Murphy, 1994). H
(B) Schematic diagram of three different models for pore formation
by CDCs. Protein is colored cerise, membrane is colored aquama- Prine, and the pore itself is colored white. Model (i) has been pro-
Oposed particularly by Tweten and colleagues (e.g., Heuck et al.,
m2003). In this case, only full ring pores insert, and, until that stage,
the CDC oligomer remains in a prepore, uninserted state. Model (ii) m
has been proposed by Palmer et al. (1998), for example. In this c
case, the nascent CDC oligomer forms a pore even when an arc b
and, in that state, increases in size. The result is a mixture of pro-
qtein-only and protein-lipid pores. This model also envisages that
otwo arcs could come together to define a protein-only pore, as
tobserved microscopically (Morgan et al., 1994; Palmer et al., 1998).
This model is not consistent with the evidence for prepore forma- a
tion (Heuck et al., 2003). Model (iii) is a previously proposed hybrid t
model (Gilbert, 2002) in which there are two oligomeric states, pre- 1
pore and pore; however, the moment of transition depends on fac-
ttors other than the completeness of the oligomeric ring. This model
talso allows for double-arc pores, as shown, but it is consistent with
oprepore formation also.
a
t
srefolded into a β sheet consisting of twinned β hairpins
(Heuck et al., 2000; Hotze et al., 2002; Ramachandran o
tet al., 2004; Tilley et al., 2005) (Figures 2B and 2D). It
has also been shown in several cases that oligomeriza- i
ttion of CDCs can occur in solution before membrane
binding, although this would inactivate the toxin with o
arespect to any subsequently encountered lipid bilayer
(Smyth et al., 1975; Cowell et al., 1978; Mitsui et al., c
f1979; Niedermeyer, 1985; Gilbert et al., 1998, 1999b). In
the case of pneumolysin, at least, not only arc and ring i
boligomers, but also helical oligomers, can form (Figure
2C). The stoichiometry of prepores and pores varies; A
testimates have varied fromw33 subunits (Gilbert et al.,
1999a) to 34–36 subunits (Czajkowsky et al., 2004); Til- t
tley and coworkers reconstructed a 31-mer prepore and
a 38-mer pore (Tilley et al., 2005), and Olofsson et al. c
v(1993) suggested 50 subunits. Overall, ring-shaped pre-ores and pores have a diameter of 30–35 nm but are
ot always complete rings; sometimes, they appear to
e arcs (Bhakdi et al., 1985; Morgan et al., 1994; Bayley,
997; Palmer et al., 1998). The suggestion has been
ade that in the case of arciform oligomers the wall
efining the pore through the membrane is completed
y part of the lipid bilayer (Bhakdi et al., 1985; Palmer
t al., 1998), but this contention has proved highly con-
roversial (Bayley, 1997; Gilbert, 2002; Heuck et al.,
003) (Figure 1B). The controversy has centered on two
actors: the stability of such a structure (Bayley, 1997)
nd the all-or-nothing character of the pore-forming
vent (Menestrina et al., 1990; Heuck et al., 2003). Many
ould consider the debate about arc pores to be con-
luded in favor of their being artifacts, but there is per-
isting evidence that arcs can form pores, as discussed
elow, and, in truth, the question is still open.
To summarize at this stage, it seems that there are
hen two outstanding questions of major interest con-
erning the mechanism of CDC pore formation. First,
hat stops the oligomerization of the toxins in solution
ince the prepore conformation is so similar to the con-
ormation of the monomeric toxin (Rossjohn et al.,
997; Gilbert et al., 1999a; Gilbert, 2002; Tilley et al.,
005)? Second, are the pores formed by CDCs always
onstituted by complete ring-form oligomers (Bhakdi et
l., 1985; Morgan et al., 1994; Palmer et al., 1998;
euck et al., 2003; Czajkowsky et al., 2004)?
reventing Premature Oligomerization
ligomerization is inherent to the process of pore for-
ation. How do CDCs prevent oligomerization prior to
embrane interaction? Listeriolysin is unique in be-
oming activated at endosomal pH (Jones et al., 1996),
ut with no other CDC has such a neat answer to the
uestion been identified. In the case of pneumolysin,
ligomeric structures can readily be observed in solu-
ion at higher protein concentrations (>1 mg/ml) that
ppear to be identical to those seen on membranes in
he pore-forming and prepore state (Gilbert et al., 1998,
999a, 1999b; Gilbert, 2002); more sensitive assays de-
ect their formation at lower concentrations, such as
he 0.36 mg/ml used by Solovyova et al. (2004). This
ligomerization in solution is concentration dependent
nd can be promoted by transferring the toxin to deu-
erated water (inducing an isotope effect on molecular
olubility) (Gilbert et al., 1998, 1999b). The way in which
ligomerization in solution is induced by toxin concen-
ration suggests that, in the case of pneumolysin, bind-
ng a membrane promotes oligomerization by concen-
rating the protein on a plane. Indeed, helical oligomers
f pneumolysin also occur in solution (at 5–10 mg/ml
nd particularly in heavy water), and these arise be-
ause the process is not occurring on a plane. These
indings also suggest that terminating oligomerization
s somehow related to the exhaustion of free toxin (Gil-
ert et al., 1999a, 1999b; Gilbert, 2002; see Figure 2C).
nother way of looking at the same point is to say that
here is an entropic cost in passing from monomeric
oxin to oligomeric toxin that will require compensation;
he chemical energy of the mass action of high local
oncentrations of monomers (either in solution or by
irtue of membrane binding) provides this compensa-
Review
1099Figure 2. Structural Acrobatics of CDCs
(A) A slice through the three-dimensional
cryo-EM reconstruction of the prepore form
of pneumolysin is shown on the left, and a
view of the surface of the whole structure is
shown on the right (Tilley et al., 2005).
(B) As (A), for the pore structure.
(C) The previously determined helical oligo-
mer formed by pneumolysin in concentrated
solution. The conformational similarity be-
tween the subunits in this oligomeric form
and the pore is obvious. This helix first dem-
onstrated the orientation of CDC monomers
within oligomers (Gilbert et al., 1999a; con-
trast with Rossjohn et al., 1997).
(D) Close-up views of the subunit profiles of
each kind of pneumolysin oligomer, with
atomic fits. On the left, the atomic structure
of perfringolysin as solved by X-ray crystal-
lography (Rossjohn et al., 1997) is fitted to
the prepore subunit. The different domains
are colored, and the pore-forming helices in
domain 3 are shown in a semitransparent
fashion. In the middle, the pore conformation
is shown, and the helical conformation is
shown on the right. The same model is
shown fitted in both of these cases and was
obtained for the helical oligomer by rotating
the four domains of perfringolysin with re-
spect to each other (Gilbert et al., 1999a).
Domain 3 is shown in red for a conformation
in which its core β sheet would form the up-
per portion of a continuous β wall completed
by the refolded helices; again, it is displayed
semitransparently. In the case of the helical
fit, domain 3 is also shown in gray with the
same relationship to the fitted domain 1 as
found in the crystal structure, to show how
conformational changes sterically exclude it
from that position. The images in this figure
were drawn by using Bobscript and were
rendered in Raster3D (Esnouf, 1999; Merritt
and Murphy, 1994). The prepore and pore
maps are as reported in Tilley et al. (2005)
and are from the EM Database (http://www.
ebi.ac.uk/msd-srv/emsearch/index.html),
deposition codes EMD-1106 and EMD-1107.tion. The helices formed in solution appear to consist
of pneumolysin molecules in the same conformation as
those found in the pore-forming, membrane bound
oligomer (contrast Figures 2B and 2C and also see Fig-
ure 2D). This is interesting, as it suggests that the ener-
getically favorable oligomeric state is the pore-forming
one and that the formation of the prepore state requires
a membrane (oligomerization is energetically constrained
by the membrane—in agreement with the insight that
pore formation on the membrane is temperature depen-
dent [Shepard et al., 2000; Tilley et al., 2005]. I am
grateful to Gregor Hofmann for discussions relating to
these points). The problem then arises of why pneumo-
lysin, and other CDCs capable of solution oligomeriza-
tion, do not unproductively oligomerize in solution
in vivo. One factor relating to this is that obviously the
concentrations needed for toxin to oligomerize in solu-
tion are higher than those needed on the membrane,
and it may be that these concentrations are not
achieved during infection. Another is that pneumolysin
is not released until S. pneumoniae cell lysis, relativelylate in infection (Morgan et al., 1996). This sequestration
of toxin may allow it to reserve oligomerization until it
has associated appropriately with a membrane.
The dominant model for the mechanism of CDC ac-
tivity is based on experiments carried out with perfingo-
lysin by Tweten, Johnson, and colleagues. This work
has largely provided our understanding of the confor-
mational changes undergone by CDCs in pore forma-
tion and has identified the parts of the proteins interact-
ing with the membrane (reviewed above). More recently,
they have addressed issues surrounding the inactiva-
tion (so that they do not prematurely oligomerize) and
subsequent activation of the CDCs on membrane bind-
ing. Oligomerization by perfringolysin in solution was
not detected at 10 mg/ml (Ramachandran et al., 2004),
and hence the question arises of why perfringolysin dif-
fers from pneumolysin in this respect since pneumo-
lysin does oligomerize, even at relatively low concen-
trations (Gilbert et al., 1998; Solovyova et al., 2004).
Tweten et al. (2001) base their model for the activation
of CDC oligomerization on the assumption that perfrin-
Structure
1100golysin is a monomer (Ramachandran et al., 2004; Czaj- o
mkowsky et al., 2004). Previously, evidence was found for
allosteric coupling between domains 4 and 3 in oligo- o
imerization of CDCs, and this suggests a way in which
binding of membranes by domain 4 might activate do- s
amain 3 for oligomerization. Experiments showed that
mutations in the membrane-inserting portions of do- g
wmain 3 altered the rate at which perfringolysin bound
to the membrane (Heuck et al., 2000). However, be- i
tcause in these experiments oligomerization directly fol-
lowed binding, an alternative explanation accounting G
afor allosteric effects of domain 4 on domain 3 is that
oligomerization and pore formation were affected by o
(the mutations and that this, in turn, had an indirect ef-
fect on binding (see below). Now, new evidence for an e
callosteric activation of domain 3 by domain 4 binding
membranes has been found. Ramachandran et al. l
(2004) used reversible inactivation of the toxin by disul-
phide crosslinking and fluorescent analyses to show o
achanges in the oligomerization interface of perfringo-
lysin after membrane binding. Precisely, (i) reversible w
scrosslinking of two residues in the monomer-monomer
interface of domain 3 inhibits pore formation because g
athe toxin is prevented from oligomerizing, but can bind
cholesterol-containing liposome membranes (this cross- d
Rlinking then becomes a way of ensuring that oligomer-
ization does not occur); (ii) fluorescent tagging of a bur- 1
oied residue in domain 3 shows that it becomes solvent
exposed upon pore formation, and that the time scale g
vof this fluorescence is similar to that of fluorescent
changes in domain 4 as a result of membrane binding, s
abut is shorter than the time scale of pore formation.
When crosslinking as in (i) inhibits oligomerization, 20% t
fof the fluorescence change found in active toxin is ob-
served, suggesting a limited rearrangement of the re- S
tgion containing the labeled residue when oligomeriza-
tion does not take place, or, the authors suggest, the v
apresence of some non-crosslinked toxin capable of
oligomerizing. p
lRamachandran et al. (2004) therefore conclude that
a conformational change allosterically caused in do- i
cmain 3 by membrane binding activates the CDCs for
oligomerization. However, this conformational change [
wwould need to originate in domain 4 (Figure 1A) and
then be communicated through the rest of the molecule g
vto the first and third domains that form the major oligo-
meric crosslinks in both prepore and pore-forming 2
pstates; as can be seen in Figure 1A, the connections
between domain 4 and the rest of the molecule are d
frather limited. Thus a direct allosteric effect arising
from membrane binding by CDCs seems inherently t
wrather unlikely. Furthermore, it is also possible that the
conformational changes observed result from oligo-
(merization. Nevertheless, these observations suggest a
mechanism for CDC activation by membrane binding a
l(Ramachandran et al., 2004). Perplexingly, however,
pneumolysin, cereolysin, streptolysin, and, indeed, per- w
gfringolysin have been documented spontaneously oligo-
merizing in the absence of membranes or cholesterol m
s(Smyth et al., 1975; Cowell et al., 1978; Mitsui et al.,
1979; Niedermeyer, 1985; Gilbert et al., 1998, 1999b). o
fThis spontaneous oligomerization of perfringolysin runs
counter to the more recent evidence mentioned above, m
sbut it is probably an effect of concentration and/or meth-ds of detection. For example, negative stain electron
icroscopy as a method of identifying the presence of
ligomers (Mitsui et al., 1979) has the potential to be
mmensely sensitive since a single oligomer can be ob-
erved, which cannot be done with gel staining (Shep-
rd et al., 2000). The effective concentration of perfrin-
olysin was also greatly increased, in those studies
here oligomers were found in solutions that had not
nteracted with membranes, by the application of nega-
ive stain, which could effectively salt out the protein.
iven that, however, the precipitation of proteins usu-
lly results in amorphous aggregates, not ordered
ligomers reminiscent of those seen on membranes
Mitsui et al., 1979); thus, it is as though the dehydrating
ffects of negative stain are here unlocking an inherent
apacity of perfringolysin even in the absence of a
ipid bilayer.
The forgoing notwithstanding, while pneumolysin
ligomerizes spontaneously in solution, perfringolysin
s a general rule seems not to. Why? The answer may
ell lie in the crystal structure of perfringolysin and in
ubsequent studies on the solution behavior of perfrin-
olysin compared to pneumolysin. Perfringolysin is an
ntiparallel dimer in all of the crystal forms studied to
ate, both those published (PDB reference 1PFO;
ossjohn et al., 1997) and unpublished (1M3I and
M3J) (Figures 3A and 3B). Whether this dimerization
ccurs through a crystallographic or noncrystallo-
raphic symmetry axis is irrevelant to its significance;
ery often dimeric forms of proteins showing proper
ymmetry observed in crystals turn out to be function-
lly significant states. It is extraordinarily unlikely that
he same dimerization could be observed in three dif-
erent crystal forms and not be biologically relevant.
till, what matters is to demonstrate that the dimer has
he characteristics expected of a physiologically rele-
ant one and that it occurs in dilute solution as well
s in the crystallographic environment. Analysis of the
erfringolysin crystallographic dimer suggests that it is
ikely to be physiologically relevant: the dimerization
nterface buries 508 Å2 with a shape complementarity
oefficient of 0.557 (programs AREAIMOL and SC;
CCP4, 1994]); this surface area of interaction is firmly
ithin the range expected biologically (Carugo and Ar-
os, 1997). By contrast, proaerolysin (in which the rele-
ance of dimerization is not in question; Barry et al.,
001) has a large interface of 1265 Å2, but a shape com-
lementarity coefficient of only 0.425. Intermedilysin is
imeric when crystallized, but the interface is different
rom that observed for perfringolysin and is more likely
o be a crystallization artifact; 348 Å2 are buried, but
ith a shape complementarity coefficient of 0.625.
In earlier studies, Mitsui et al. (1979) and Cowell et al.
1978) examined the solution behavior of perfringolysin
nd cereolysin, respectively. In the first case, perfringo-
ysin was found as arc- and ring-shaped oligomers
hen examined by negative stain electron microscopy;
el filtration studies suggested, however, that the oligo-
erization process was induced by the stain itself (Mit-
ui et al., 1979). An estimate of the molecular weight
f the single main peak found for perfringolysin on gel
iltration was not made, and it could relate to mono-
eric or dimeric toxin. In any case, it seems that the
tain has either disrupted the dimerization or has pro-
Review
1101Figure 3. Comparison of Bacterial Pore-
Forming Toxins
(A) Ribbon representation of the perfringo-
lysin crystal structure, colored from blue at
its amino terminus to red at the carboxy ter-
minus. The domains are labeled: the com-
plex structure of domains 1–3 together con-
trasts the more separate domain 4.
(B) The dimeric form of perfringolysin found
in the crystal structures and in solution. One
monomer is colored aquamarine and is in
the same position as the single molecule in
(A); the other monomer is colored blue.
(C) Antiparallel dimer of proaerolysin (Parker
et al., 1994). The monomers are colored
aquamarine and cerise; the propeptide, pro-
teolytic removal of which activates the pro-
toxin to aerolysin, is colored blue.
(D) Monomeric structure of Bacillus anthracis
protective antigen, PA (Petosa et al., 1997).
(E) Structure of the staphylococcal α-hemo-
lysin heptamer with one subunit colored and
adjacent, of the monomeric form of the toxin,
solved for the related LukF protein, with equiv-
alent regions colored as in the main image
(Song et al., 1996; Olson et al., 1999). The
images in this figure were drawn by using
Bobscript and were rendered in Raster3D
(Esnouf, 1999; Merritt and Murphy, 1994).moted oligomerization by the remaining monomer, if the
protein is predominately dimeric. A mixture of states
with dimer predominating is supported by the presence
of a right-hand shoulder on the gel filtration elution
peak. In contrast, Cowell et al. (1978) did examine the
molecular weight of cereolysin, by using analytical ul-
tracentrifugation as well as gel filtration. It was shown
that cereolysin was overwhelmingly monomeric in solu-
tion, but oligomers were identified as having formed
spontaneously by the use of negative stain and metal
shadow electron microscopy. Again, it was felt that the
oligomerization observed in solution was likely to be
an artifact of preparing specimens for electron micros-
copy; of course, the monomeric nature of cereolysin
chimes with that of pneumolysin (Morgan et al., 1993;
Solovyova et al., 2004) and does not alter the question
as to whether perfringolysin’s dimer is real or not.
Now, Solovyova et al. (2004) have addressed dimeriza-
tion of perfringolysin in dilute solution: in a comparative
study with pneumolysin, they reiterated the previous con-
clusion that pneumolysin is generally monomeric but has
a tendency to oligomerize in solution, and then they
showed that perfringolysin is predominately dimeric, with
some monomer. Furthermore, these authors performed
small-angle scattering studies on perfringolysin and
concluded that it was an antiparallel dimer (Solovyova
et al., 2004) on the basis of direct analysis of scatteringcurves by using the new generation of curve-analysis
software that can derive molecular envelopes for pro-
teins (Svergun, 1999). This conclusion was reached in-
dependently of reflection on the crystal structure dimer
and was published without reference to it, but the work
clearly agrees with it. This antiparallel dimer formed by
pefringolysin in solution is shown in Figure 2B and pro-
vides an answer to the failure of perfringolysin to be-
have like monomeric pneumolysin: CDC oligomers
involve subunits in parallel contacts, not antiparallel
ones. This dimeric arrangement compares very inter-
estingly to that of aerolysin from Aermonas hydrophila,
in which the pro-toxin exists as an antiparallel dimer
and must dissociate to form a heptamer of parallel sub-
units (although in the case of aerolysin, there is also a
proteolytic activation stage; Figure 3C) (Parker et al.,
1994). Furthermore, in the case of perfringolysin, it is
known that the receptor binding domain is domain 4,
which is shielded from direct interaction with the mem-
brane by being packed against domain 1 of each mole-
cule’s antiparallel twin. While a protein receptor would
stand proud enough of the membrane to bind domain
4 of this dimer, cholesterol would not. Since cholesterol
is sufficient to get perfringolysin to form pores in mem-
branes (in the paper describing apparent membrane-
dependent activation of perfringolysin for oligomerization,
cholesterol-containing liposomes were used; [Ramachan-
Structure
1102ldran et al., 2004]), it is suggested here that monomers,
inot dimers, of perfringolysin bind to the membrane; the
pdimers are essentially inert and represent the biolog-
cically significant way in which the toxin is delivered
bprior to acting at a membrane. Since the dimeric form
iof the toxin is in equilibrium with the monomeric form
b(Solovyova et al., 2004), this would draw the equilibrium
aover toward the monomer and so cause the binding of
iincreasing amounts of toxin to the membrane. If a pro-
stein receptor for perfringolysin were to play a role in vivo
rin toxin activity, this could cause the binding of dimers
sto the membrane. Nevertheless, they would need to be-
ccome monomeric and associate directly with the mem-
rbrane surface before they could proceed to oligomerize
into the prepore. This then provides a mechanism for
membrane-determined activation of perfringolysin— C
Hnot by invoking allostery as a result of membrane bind-
ing, but by using the toxin’s inherent affinity for choles- i
lterol to alter the position of a monomer-dimer equilib-
rium and so drive the partition of toxin onto the lipid t
(bilayer and into oligomers. Since monomer binding
itself is reversible (Palmer et al., 1995), this mechanism S
sexplains why mutations in domain 3 affect binding by
domain 4: if mutant toxin does not oligomerize and n
Fform pores as efficiently as wild-type, as reported
(Heuck et al., 2000), then the apparent rate of toxin t
ibinding will be lower due to a shift in equilibrium back
toward unbound monomers and therefore back toward i
sinactive toxin dimers (Figure 4). In conclusion, and to
emphasize the form of the argument being put forward, m
tthere appear to be two ways in which CDCs have been
observed associating in solution. These different ways t
mare entirely distinct. On the one hand, pneumolysin
oligomerizes in a parallel topology into arc, ring, and m
fhelical oligomers. On the other hand, perfringolysin
forms an antiparallel dimer in solution. It is the tentative b
tsuggestion of this review that the dichotomy repre-
sented by these two modes of self-interaction is ex- (
2plained by the difference in their topologies. Perfringo-
lysin cannot form parallel oligomers while it takes the l
fform of an antiparallel dimer, and this is the reason it
does not form oligomers in solution. t
tIf perfringolysin is in a dynamic equilibrium between
monomeric and dimeric forms, but monomers can al- ct
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2Figure 4. Schematic of the Interactions Undergone by Perfringo-
lysin and Pneumolysin in Solution (
tPerfringolysin is shown in the dotted box, and pneumolysin is
shown by the dashed box. The two modes of self-interaction seem- m
ingly open to CDCs are dimerization (blue box) or oligomerization o
(pink box). Arrow thickness indicates affinity. a
mernatively drain irreversibly into oligomers (Figure 4),
hy isn’t all of the monomer steadily converted to
ligomer and thus all the dimer eventually converted
lso, via a constant movement of the monomer-dimer
quilibrium toward monomers? The answer to this
uestion lies in the concentration dependence of oligo-
erization evident in the case of pneumolysin, which is
ot a dimer and whose monomers can convert irrevers-
bly to oligomer. There is not sufficient monomeric per-
ringolysin around to oligomerize significantly at lower
oncentrations, while, at higher concentrations, PFO is
verwhelmingly dimeric anyway (see Solovyova et al.,
004). Furthermore, this has been seen experimentally
Solovyova et al., 2004): it appears that at concentra-
ions at which perfringolysin is basically dimeric (0.13
g/ml), pneumolysin displays only a weak tendency to
ligomerize slowly in solution (at 0.36 mg/ml). Thus, the
ffinity of perfringolysin for itself in dimerizization is
uch greater than the affinity for monomeric pnemo-
ysin in oligomerization. This affinity of pneumolysin for
tself is a good probe for the affinity of any monomeric
erfringolysin for itself in oligomerization, and it indi-
ates that the preference of a dimeric state displayed
y perfringolysin will protect it from forming oligomers
n solution. The affinity of CDCs for cholesterol in mem-
ranes is of the order of 10−7–10−9 M (Ohno-Iwashita et
l., 1988). Thus, binding of monomers to the membrane
n the case of a predominately dimeric toxin will deci-
ively alter the balance of its monomer-dimer equilib-
ium toward monomers and cause it to partition from
olution onto the membrane. Dimers, as noted above,
annot bind the membrane surface itself due to steric
easons.
omparison with Other Pore-Forming Toxins
aving discussed the solution behavior and oligomer-
zation of CDCs such as perfringolysin and pneumo-
ysin, it is interesting to compare them to pore-forming
oxins such as aerolysin, anthrax protective antigen
PA) (Figure 2D), and the archetypal pore-forming toxin
. aureus α-hemolysin (Figure 2E). In doing so, one is
truck by the similarities in their structure and mecha-
isms as well as their differences. As is apparent from
igure 3, their structures are quite different, although
hey all have a significant proportion that is a β sheet;
n all four cases, the pore-forming region of the protein
s also a β sheet. In α-hemolysin, PA, and aerolysin, a
ingle β hairpin is provided by each of the seven mono-
ers in the pore-forming state (Song et al., 1996; Pe-
osa et al., 1997; Melton et al., 2004); in perfringolysin,
wo β hairpins are provided within a pore-forming oligo-
er of 30–40 subunits (Shatursky et al., 1999). These
embrane-inserting structures are derived from dif-
erent kinds of structures in the monomeric, water-solu-
le toxin: in α-hemolysin and aerolysin, these struc-
ures are derived from an ordered β-sheeted region
Olson et al., 1999; Pedelacq et al., 1999; Melton et al.,
004), and, in PA, they are derived from a disordered
oop (Petosa et al., 1997) and from six α helices in per-
ringolysin and other CDCs (Shatursky et al., 1999). In
he cases of α-hemolysin, PA, and perfringolysin, the
oxin is known to go through a prepore state that then
onverts in a concerted manner to a pore-forming state
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Santelli et al., 2004; Heuck et al., 2003); in aerolysin,
this may be the case, though the prepore state has not
been characterized. Finally, the ways in which the tox-
ins are delivered and the way in which they are pre-
vented from inappropriate formation of oligomeric
pores varies; aerolysin is proteolytically activated at the
membrane surface and is delivered as a dimer (Barry
et al., 2001), while PA, too, is proteolytically activated,
but is also pH sensitive (Petosa et al., 1997; Miller et
al., 1999; Lacy et al., 2004; Santelli et al., 2004). In the
case of α-hemolysin, the toxin molecule is monomeric
in solution but assembles into its heptameric prepore
structure after binding the membrane via an unknown
receptor; the crystal structure of α-hemolysin was solved
for toxin that had been converted to its pore-forming
structure by being mixed with deoxycholate (Bhakdi et
al., 1981; Song et al., 1996). Thus, the structural varia-
tions in these toxins using β-sheeted structures to form
pores underlie variations in their mechanisms of deliv-
ery and pore formation. Like pneumolysin, α-hemolysin
can be induced to undergo the structural transition it
makes when membrane bound, though in the absence
of membranes (Bhakdi et al., 1981). In the case ofα-hemo-
lysin, this yields heptamers (Song et al., 1996), with
pneumolysin solution-formed oligomers of varying sizes
including arcs, rings, and helices (Gilbert et al., 1999a)
(Figure 2C).
Forming Pores with Incomplete Rings
The second issue that remains unresolved concerning
CDCs is the role of arc oligomers in pore formation.
While it has been established that oligomerization to a
prepore precedes pore formation (Menestrina et al.,
1990; Shepard et al., 2000; Hotze et al., 2001; Heuck et
al., 2003), it has not been established whether those
pores are always rings of toxin and cannot be arcs, as
has previously been suggested (Bhakdi et al., 1985;
Palmer et al., 1998). Indeed, there is good evidence
that, while pores form in a quantized fashion, they vary
considerably in size (Menestrina et al., 1990; Korchev
et al., 1998); for example, some are blockable by a 15
kDa protein, while others cannot be blocked by 40 kDa
polysaccharides (Korchev et al., 1998). It has also been
shown that smaller oligomers of CDC produce smaller
pores (Palmer et al., 1998, although, see Heuck et al.,
2003), which lends support to the idea that prepores
(and therefore the resulting pores) can be quite varied
in size and include arcs as well as rings. How can quan-
tized (all-or-nothing) pore formation events occur if the
pores vary in size? A previous discussion of this ques-
tion proposed that incomplete prepore structures are
metastable and that membrane insertion occurs when
monomer recruitment slows due to depletion of local
concentrations of toxin; that is, that the population of
pore sizes formed is the result of a competition be-
tween prepore growth and pore insertion (Gilbert, 2002;
see discussion above concerning helical oligomers).
In a recent paper, Tweten and colleagues observed
prepores and pores of perfringolysin by using atomic
force microscopy (AFM) (Czajkowsky et al., 2004). They
show clearly that the CDCs undergo a dramatic confor-
mational change, with a vertical collapse of the preporehammering the pore-forming portions of the toxin into
the membrane. In parallel, Tilley et al. (2005) have ob-
served native pores in structural detail for the first time
in liposome membranes, which provides a molecular
level of description concerning the conformational
changes of the CDCs in pore formation. Such structural
results are critically important to set more indirect in-
sights from, for example, fluorescence experiments, in
context. The structures of prepores and pores ob-
served by AFM were formed within supported single
lipid bilayers and clearly show the presence of arcs as
well as rings in both states (Figures 2 and 3 in Czajkow-
sky et al., 2004). The presence of arcs is not com-
mented on in Czajkowsky et al. (2004) other than to
note their existence. The key discriminator between
prepores and pores in these images is that the prepores
rise to a height of 113 Å above the membrane (as ex-
pected, the height of the monomeric toxin; Gilbert et
al., 1999a; Tilley et al., 2005), while the pores have col-
lapsed so that they stand only 73 Å proud of the surface
(Czajkowsky et al., 2004). In the images published, ap-
proximately half of the pore structures are arcs, and a
plot is shown of the constant 73 Å height of the oligo-
mers above the bilayer surface (Figures 2 and 3 in Czaj-
kowsky et al., 2004). This strongly indicates that the
arcs are in a pore-forming conformation, not a prepore
one, since oligomers of 113 Å height would have shown
up in the data in w50% of the population. These data
therefore suggest that either these oligomers are ring-
shaped pores that have broken up due to experimental
handling, or they are arc pore-forming oligomers. Since
it has been reported that CDC oligomers, once formed,
are stable even in SDS (which allows their analysis by
gel electrophoresis) (Shepard et al., 2000), the second
explanation (that the arcs are genuine pores) seems
more likely since pore-forming oligomers should not fall
apart into arcs.
Interestingly, there is a higher proportion of arciform
oligomers seen in images of pores than in images of
prepores. This is consistent with a previously proposed
model for pore formation in which the prepore arcs are
metastable, and whether oligomerization to a complete
ring occurs before pore formation depends on how rap-
idly toxin can be recruited to the nascent oligomer (Gil-
bert, 2002). In that model, arc-form prepores have a
tendency to convert to pores when recruitment of toxin
to the nascent oligomer slows or stops due to local
depletion of monomeric CDC. Once pore formation oc-
curs, no further monomers can be added to the arc be-
cause the conformation of CDC competent for recruit-
ment on membranes is the prepore one, not the pore
conformation (and these are now known to be very dif-
ferent [Czajkowsky et al., 2004; Tilley et al., 2005]; but,
note that in solution the pore conformation does seem
to be extendible, as in the case of helices discussed
above). On the other hand, ring oligomers will tend to
form if conversion to a pore cannot occur or is retarded.
In the previous discussion, this was related to a muta-
tion (Trp433Phe) in pneumolysin that reduces toxin ac-
tivity by 99% but allows the formation of the larger
kinds of pores (Korchev et al., 1998; Gilbert, 2002);
powerful confirmation that the Trp-rich loop (containing
Trp433 in pneumolysin) influences the prepore-to-pore
conversion has recently been provided through the
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et al., 2005). In the more recent AFM work, pore forma- t
tion was prevented by disulphide crosslinking, which c
could then be reduced to allow pore formation (Czaj- t
kowsky et al., 2004). A series of AFM images taken as d
disulphide-inactivated prepores convert to pores fol- o
lowing reduction supports the argument that pores are w
as likely to be formed from arcs as from rings since, in f
this case, most pores are rings (Figure 4 of Czajkowsky d
et al., 2004). That is, when oligomers can form pores a
immediately following oligomerization, they are as likely
to be arcs as rings. When oligomers can only form pre- A
pores, they will tend to get as far as complete rings and
Rnot tend to stick at arcs because they have no alterna-
ftive; when those rings are unlocked and so allowed to
A
convert to pores, they remain rings (indicating that it
is not something inherently unstable about pores that
Rcauses the greater number of arcs seen in images of
R
them, but a basic aspect of the way they form in the A
context of toxin possessing native activity). In any case, P
the evidence of the recent AFM study is that arcs can
constitute pores, and thus it is still unclear, 20 years R
after arcs of CDCs were first suggested to have the
Acapacity to form pores (Bhakdi et al., 1985), whether
rin fact they do or not. Indeed, dispassionate analysis
I
suggests that arcs are capable of defining pores. e
Finally, the question of how a pore could possibly be
B
structured partly from protein and partly from lipid T
should briefly be addressed. There are other systems c
in which protein rings open toward lipid membrane to B
create a composite channel walled by protein on one R
side and lipid on the other: the translocon through B
which membrane proteins cotranslationally partition a
Sinto the endoplasmic reticulum membrane from bound
mribosomes (White and von Heijne, 2004); the comple-
Yment membrane attack complex (Tranum-Jensen and
BBhakdi, 1983; Tschopp, 1984; Malinski and Nelsestuen,
c1989); and pores formed by the C domains of colicins
a
(Zakharov et al., 2004). The structure that the lipid d
would take along its edge partially lining the pore has
B
been suggested to be such that the bilayer remains o
continuous, with its hydrophobic-hydrophilic polarity
B
unaltered (Tschopp, 1984; Malinski and Nelsestuen, t
1989), equivalent to the bicontinuous structure reminis- 2
cent of a cubic lipidic phase that entirely surrounds the B
pores formed during electroporation of lipid mem- (
abranes (Weaver, 2003; Gehl, 2003; Leontiadou et al.,
C2004). This has been referred to as the toroidal model
Bfor pore formation (Zakharov et al., 2004). Furthermore,
athe pore would not need to be a particularly stable
mstructure—what matters is significant leakage, causing
Ceither downstream signaling (Morgan et al., 1996) or
csignificant osmotic shock, not long-term conductance
C(Gilbert, 2002). Comparing electroporation pores with
Ctoxin pores suggests another possibility—that the in-
D
sertion of the arcs generates a hemicircular pore in a
Csimilar way to that envisaged by Müller et al. (2002) dur-
c
ing electroporation and the action of influenza hemag- B
glutinin (Kozlov and Chernomordik, 1998; Bonnafous
C
and Stegmann, 2000; Müller et al., 2002). This pore V
could be partly defined by the arc, or adjacent to the β
arc, having arisen simply as a result of the destabiliza- E
tion of the membrane by insertion of an amphipathic c
Cprotein structure (Shatursky et al., 1999). In this way,nsertion of protein would be equivalent to destabiliza-
ion of the membrane by an electric field and indeed
ould arise from dipolar or other electrostatic proper-
ies of proteins (I am grateful to Andreas Sonnen for
rawing my attention to this possibility and to the work
f Müller et al. [2002]). Comparing CDC pore formation
ith fusion events is particularly appropriate given the
act that pneumolysin, at least, has been shown to in-
uce membrane fusion and blebbing events (Bonev et
l., 2000, 2001; Gilbert, 2002).
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